Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82


Noninvasive identification of viable cell populations in docetaxel-treated breast tumors using ferritin-based magnetic resonance imaging.

Choi Y, Kim HS, Cho KW, Lee KM, Yi YJ, Eun SJ, Kim HJ, Woo J, Choi SH, Whangbo TK, Choi C, Noh DY, Moon WK.

PLoS One. 2013;8(1):e52931. doi: 10.1371/journal.pone.0052931. Epub 2013 Jan 2.


Noninvasive MRI and multilineage differentiation capability of ferritin-transduced human mesenchymal stem cells.

Kim HS, Woo J, Choi Y, Hwang EH, Choi SK, Cho KW, Moon WK.

NMR Biomed. 2015 Feb;28(2):168-79. doi: 10.1002/nbm.3236. Epub 2014 Dec 1.


An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer.

Lee HE, Kim JH, Kim YJ, Choi SY, Kim SW, Kang E, Chung IY, Kim IA, Kim EJ, Choi Y, Ryu HS, Park SY.

Br J Cancer. 2011 May 24;104(11):1730-8. doi: 10.1038/bjc.2011.159. Epub 2011 May 10.


In vivo imaging of tumor transduced with bimodal lentiviral vector encoding human ferritin and green fluorescent protein on a 1.5T clinical magnetic resonance scanner.

Kim HS, Cho HR, Choi SH, Woo JS, Moon WK.

Cancer Res. 2010 Sep 15;70(18):7315-24. doi: 10.1158/0008-5472.CAN-10-0241. Epub 2010 Sep 7.


In vivo Tracking of Dendritic Cell using MRI Reporter Gene, Ferritin.

Kim HS, Woo J, Lee JH, Joo HJ, Choi Y, Kim H, Moon WK, Kim SJ.

PLoS One. 2015 May 20;10(5):e0125291. doi: 10.1371/journal.pone.0125291. eCollection 2015.


Assessment of early docetaxel response in an experimental model of human breast cancer using DCE-MRI, ex vivo HR MAS, and in vivo 1H MRS.

Jensen LR, Huuse EM, Bathen TF, Goa PE, Bofin AM, Pedersen TB, Lundgren S, Gribbestad IS.

NMR Biomed. 2010 Jan;23(1):56-65. doi: 10.1002/nbm.1426.


Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors.

Cohen B, Dafni H, Meir G, Harmelin A, Neeman M.

Neoplasia. 2005 Feb;7(2):109-17.


Erythropoietin activates cell survival pathways in breast cancer stem-like cells to protect them from chemotherapy.

Todaro M, Turdo A, Bartucci M, Iovino F, Dattilo R, Biffoni M, Stassi G, Federici G, De Maria R, Zeuner A.

Cancer Res. 2013 Nov 1;73(21):6393-400. doi: 10.1158/0008-5472.CAN-13-0248. Epub 2013 Sep 5.


RhoC impacts the metastatic potential and abundance of breast cancer stem cells.

Rosenthal DT, Zhang J, Bao L, Zhu L, Wu Z, Toy K, Kleer CG, Merajver SD.

PLoS One. 2012;7(7):e40979. doi: 10.1371/journal.pone.0040979. Epub 2012 Jul 23.


Stem cells: their role in breast cancer development and resistance to treatment.

Nicolini A, Ferrari P, Fini M, Borsari V, Fallahi P, Antonelli A, Berti P, Carpi A, Miccoli P.

Curr Pharm Biotechnol. 2011 Feb 1;12(2):196-205. Review.


Microarray-based analysis of microRNA expression in breast cancer stem cells.

Sun JG, Liao RX, Qiu J, Jin JY, Wang XX, Duan YZ, Chen FL, Hao P, Xie QC, Wang ZX, Li DZ, Chen ZT, Zhang SX.

J Exp Clin Cancer Res. 2010 Dec 31;29:174. doi: 10.1186/1756-9966-29-174.


Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy.

Fillmore CM, Kuperwasser C.

Breast Cancer Res. 2008;10(2):R25. doi: 10.1186/bcr1982. Epub 2008 Mar 26.


Semi-quantitative evaluation of CD44(+) /CD24(-) tumor cell distribution in breast cancer tissue using a newly developed fluorescence immunohistochemical staining method.

Kai M, Onishi H, Souzaki M, Tanaka H, Kubo M, Tanaka M, Katano M.

Cancer Sci. 2011 Dec;102(12):2132-8. doi: 10.1111/j.1349-7006.2011.02063.x. Epub 2011 Sep 14.


Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models.

Liu H, Patel MR, Prescher JA, Patsialou A, Qian D, Lin J, Wen S, Chang YF, Bachmann MH, Shimono Y, Dalerba P, Adorno M, Lobo N, Bueno J, Dirbas FM, Goswami S, Somlo G, Condeelis J, Contag CH, Gambhir SS, Clarke MF.

Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):18115-20. doi: 10.1073/pnas.1006732107. Epub 2010 Oct 4.


Mevalonate metabolism regulates Basal breast cancer stem cells and is a potential therapeutic target.

Ginestier C, Monville F, Wicinski J, Cabaud O, Cervera N, Josselin E, Finetti P, Guille A, Larderet G, Viens P, Sebti S, Bertucci F, Birnbaum D, Charafe-Jauffret E.

Stem Cells. 2012 Jul;30(7):1327-37. doi: 10.1002/stem.1122.


Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation.

Louie E, Nik S, Chen JS, Schmidt M, Song B, Pacson C, Chen XF, Park S, Ju J, Chen EI.

Breast Cancer Res. 2010;12(6):R94. doi: 10.1186/bcr2773. Epub 2010 Nov 10.


Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines.

Cao L, Zhou Y, Zhai B, Liao J, Xu W, Zhang R, Li J, Zhang Y, Chen L, Qian H, Wu M, Yin Z.

BMC Gastroenterol. 2011 Jun 14;11:71. doi: 10.1186/1471-230X-11-71.


Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy.

Nishikawa S, Konno M, Hamabe A, Hasegawa S, Kano Y, Ohta K, Fukusumi T, Sakai D, Kudo T, Haraguchi N, Satoh T, Takiguchi S, Mori M, Doki Y, Ishii H.

Int J Oncol. 2013 Apr;42(4):1437-42. doi: 10.3892/ijo.2013.1837. Epub 2013 Feb 22.


Induction of metastatic cancer stem cells from the NK/LAK-resistant floating, but not adherent, subset of the UP-LN1 carcinoma cell line by IFN-γ.

Chen HC, Chou AS, Liu YC, Hsieh CH, Kang CC, Pang ST, Yeh CT, Liu HP, Liao SK.

Lab Invest. 2011 Oct;91(10):1502-13. doi: 10.1038/labinvest.2011.91. Epub 2011 Jun 20.


Ferritin reporter used for gene expression imaging by magnetic resonance.

Ono K, Fuma K, Tabata K, Sawada M.

Biochem Biophys Res Commun. 2009 Oct 23;388(3):589-94. doi: 10.1016/j.bbrc.2009.08.055. Epub 2009 Aug 14.


Supplemental Content

Support Center